MedTrace Logo

BeAT1D: Benign Autoimmunity and Type 1 Diabetes

NCT05139784 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1160

Last updated 2026-05-22

No results posted yet for this study

Summary

National multi-center non-interventional case-control cohort study with collection of biological samples to characterize the autoimmune T and B lymphocytes involved in the development of type 1 diabetes.

Conditions

Interventions

OTHER

Biosampling

Collection of blood and stool specimens; and collection of lymph node specimens for the group undergoing surgical lymphadenectomy.

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Principal Investigators

  • Roberto Mallone, MD PhD · INSERM U1016 Cochin Institute

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-24
Primary Completion
2030-04-30
Completion
2030-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05139784 on ClinicalTrials.gov